Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus



Título del documento: Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus
Revista: Anais brasileiros de dermatologia
Base de datos: PERIÓDICA
Número de sistema: 000410421
ISSN: 0365-0596
Autores: 1
2
2
1
1
1
Instituciones: 1Seventh People's Hospital of Shenyang, Department of Dermatology, Shenyang, Liaoning. China
2China Medical University, First Affiliated Hospital, Shenyang, Liaoning. China
Año:
Periodo: Jul-Ago
Volumen: 92
Número: 4
Paginación: 466-469
País: Brasil
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Analítico, descriptivo
Resumen en inglés The clinical significance of anti-neutrophil cytoplasmic antibodies in patients with new-onset systemic lupus erythematosus, especially in systemic disease accompanied by interstitial lung disease remains to be elucidated. Objectives: This study was designed to investigate the role of anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus patients. Methods: A hundred and seven patients with new-onset SLE were enrolled. Presence of anti-neutrophil cytoplasmic antibodies in the sera was assessed by indirect immunofluorescence as well as enzyme linked immunosorbent assay against proteinase-3 and myeloperoxidase. Clinical features and laboratory parameters of patients were also recorded. All patients were subjected to chest X-ray, chest high-resolution computed tomography and pulmonary function test. Results: Forty-five systemic lupus erythematosus patients (45/107, 42%) were seropositive for anti-neutrophil cytoplasmic antibodies. Compared with anti-neutrophil cytoplasmic antibodies-negative patients, the anti-neutrophil cytoplasmic antibodies-positive patients had significantly higher incidence of renal involvement, anemia, and Raynaud's phenomenon as well as decreased serum level of complement 3/complement 4 and elevated erythrocyte sedimentation rate. In addition, there was a positive correlation between serum anti-neutrophil cytoplasmic antibodies level and disease activity of systemic lupus erythematosus. Furthermore, prevalence of interstitial lung disease in the anti-neutrophil cytoplasmic antibodies -positive patients (25/45, 55.6%) was obviously higher than that in the anti-neutrophil cytoplasmic antibodies-negative patients (15/62, 24.2%). Study limitations: The sample size was limited and the criteria for screening new-onset systemic lupus erythematosus patients might produce bias. Conclusions: The level of anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythemat
Disciplinas: Medicina
Palabras clave: Dermatología,
Inmunología,
Lupus eritematoso sistémico,
Anticuerpos citoplásmicos antineutrófilos,
Enfermedad intersticial pulmonar
Keyword: Medicine,
Dermatology,
Immunology,
Systemic lupus erythematosus,
Anti-neutrophil cytoplasmic antibodies,
Interstitial lung disease
Texto completo: Texto completo (Ver HTML)